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ABSTRACT 16 
This study investigates the influence of feed solution pH and fouling on the rejection of 17 
ten selected pharmaceutically active compounds (PhACs) with different 18 
physicochemical characteristics (molecular weight, water solubility, log KOW, pKa, 19 
dipole moment…) by three multichannel ceramic ultrafiltration membranes, ranging 20 
from 1 to 8 kDa, in order to improve their removal from water. For this purpose, the 21 
comparison between filtration of PhACs in deionised water (Feed I) and in real 22 
wastewater effluent (Feed II) was performed, demonstrating that the variation of pH and 23 
the formation of a foulant layer altered the separation mechanism and hence the 24 
rejection values of each PhAC varied. Higher rejections of most of the PhACs were 25 
higher at slightly alkaline pH, especially for anionic compounds in the filtration with 26 
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real wastewater. In these conditions, flux decline was more severe. The formed fouling 27 
layer onto the hydrophilic membrane surface acted as a secondary barrier for separation 28 
with different properties like hydrophobicity and charge. Electrostatic interactions were 29 
the main separation mechanism in the filtration of PhACs in deionised water, while the 30 
hydrophobic/hydrophilic interactions played a crucial role in the filtration experiments 31 
with real wastewater effluent. Thus, the reported results indicated that the rejection of 32 
pharmaceutically active compounds was strongly pH-dependent, except for hydrophilic 33 
neutral compounds (acetaminophen and caffeine), which showed a pH-independent 34 
behaviour with low rejection values.  35 
 36 
KEYWORDS Ceramic fine ultrafiltration membranes; rejection efficiency; 37 
pharmaceutically active compounds; pH; fouling phenomena. 38 
 39 
1. INTRODUCTION 40 
Emerging contaminants have a great interest for institutions, public media and 41 
researchers due to the potential health risks associated with their release into the 42 
environment and their interactions with the landscape, human beings and wildlife 43 
species [1,2]. Several recent studies have demonstrated that emerging contaminants 44 
such as endocrine disrupting compounds (EDCs), pharmaceutically active compounds 45 
(PhACs), pesticides, disinfection by-products (DBPs), and personal care products 46 
(PCPs) are found at trace concentrations in surface waters and the toxicity of many of 47 
these compounds can potentially develop hazardous human, animal and ecological 48 
problems, depending on their nature and concentration [3-5]. Among the diversity of the 49 
emerging contaminants, the increasing use of PhACs leads to a growing occurrence of 50 
these organic compounds in wastewater and surface water, which makes them an 51 
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important environmental concern. These compounds are originated from veterinary 52 
applications and human usage and excretions (without being transformed or as 53 
metabolites), including personal hygiene products, hospital waste, therapeutic drugs, 54 
and waste from pharmaceutical industry [6]. PhACs have been detected directly or as 55 
their metabolites in surface water and effluents. As a direct consequence of their 56 
inherent biological activity, PhACs can cause unwanted adverse effects on non-target 57 
species after their release into the environment, including human/wildlife reproduction 58 
disorders and the appearance of antibiotic resistant bacteria [7,8]. These effects are 59 
related to the wide range of physicochemical properties of PhACs (including solubility, 60 
biodegradability and polarity), which favour their persistence in the environment, 61 
propensity for bioaccumulation in living organisms and capability to be transformed 62 
into products after various oxidative treatments [9]. Petrie et al. reported in 2015 that 63 
more than 200 different PhACs have been found in river waters worldwide [10].  64 
 65 
Conventional wastewater treatment plants (WWTPs) are not specially designed to 66 
remove PhACs because they usually receive and treat a large spectrum of pollutants 67 
from industrial, domestic and farming wastewater. Due to both the diverse 68 
physicochemical properties and low concentrations levels of PhACs (from ng·L-1 to 69 
μg·L-1), they are not completely eliminated during treatment processes, obtaining 70 
complex outlets which are discharged into rivers [4]. In addition, the concentration of 71 
some PhACs has increased during the treatment in WWTPs as a consequence of their 72 
transformation into conjugates [11]. Such limitations have led to explore new 73 
technological alternatives, such as advanced oxidation processes, activated carbon 74 
adsorption or membrane filtration [6,12,13]. Pressure-driven membrane separation 75 
processes such as reverse osmosis (RO), nanofiltration (NF), ultrafiltration (UF), and 76 
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microfiltration (MF) applied at pilot- and full-scale installations are being successfully 77 
used either separately or as a combination of membrane techniques in wastewater 78 
reclamation to achieve a high quality product by efficiently removing bacteria, viruses, 79 
dissolved solids, organic micropollutants, proteins, sugars or inorganic ions [14]. 80 
Several researchers have investigated the application of membrane technology in the 81 
removal of PhACs, especially in synthetic model waters where the target compounds 82 
were spiked [11]. NF and RO techniques have been successfully applied to remove 83 
PhACs and PCPs from raw wastewaters and natural waters as well, in which the 84 
influence of solute interactions between organic matter and PhACs on the membrane 85 
performance is a key parameter [12,14,15]. Generally, UF, NF and RO membranes used 86 
in PhACs removal are made of polymeric materials and, to a lesser extent, of polymeric 87 
membranes modified with inorganic particles [16,17]. Despite their use in 88 
pharmaceutical industry, from our knowledge only few studies investigated the 89 
performance of ceramic membranes to treat ground and surface waters with PhACs, 90 
especially in MF [18]. Thus, it is noteworthy to highlight that the main novelty of this 91 
work is the implementation of ceramic fine ultrafiltration membranes to remove PhACs 92 
from municipal and industrial wastewaters. Ceramic membranes were selected due to 93 
their thermal stability, superior chemical and biological resistance and adaptability for a 94 
wide pH range, even though they were more expensive than polymeric membranes 95 
[19,20].  96 
 97 
In the present work, the performance of different multichannel ceramic membranes 98 
within the fine ultrafiltration range (between 1 and 8 kDa) was studied in terms of 99 
permeate flux, membrane fouling and rejection index. A novel aspect of this work is to 100 
study the influence of the feed solution pH (ranging from 6 to 8) and the molecular 101 
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weight cut-off (MWCO) of the selected membranes on their performances. Experiments 102 
were carried out using a cross-flow membrane filtration unit with ten selected PhACs 103 
with diverse physicochemical characteristics added in deionised water (Feed I) and in a 104 
WWTP secondary effluent (Feed II).  105 
 106 
2. EXPERIMENTAL 107 
2.1.WWTP secondary effluent samples 108 
WWTP secondary effluent samples were donated by Carraixet WWTP, located in the 109 
region of Valencia (Spain). The characterisation of such samples was performed 110 
according to Standard Methods [21]. Their physicochemical characteristics are 111 
summarised in Table 1. This effluent is slightly alkaline with a high electrical 112 
conductivity, turbidity and a moderate COD value compared with the wastewater used 113 
in similar studies by other researchers [22]. 114 
 115 
2.2.Chemicals and Materials 116 
Ten PhACs (acetaminophen, caffeine, diazepam, diclofenac, erythromycin, ibuprofen, 117 
naproxen, sulfamethoxazole, triclosan, and trimethoprim) were examined. All of them 118 
were high reagent purity grade (≥ 99 %) and purchased from Sigma-Aldrich (Germany). 119 
These PhACs were selected due to their occurrence and persistence in effluents from 120 
WWTPs and surface water at the Spanish Mediterranean area of Valencia [23,24]. Their 121 
main physicochemical properties are summarised in Table 2. These organic compounds 122 
have similar molecular weight (except erythromycin) and distinguishing features 123 
including water solubility, molar volume, log KOW, pKa, and dipole moment, which 124 
make them interesting to be compared. The pH of feed solutions was adjusted using 0.1 125 
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M HCl/NaOH solutions before starting filtration experiments and was controlled using a 126 
Crison pH meter. Both chemicals (HCl and NaOH) were obtained of reagent grade from 127 
Panreac (Spain). Deionised water was used throughout this study.  128 
 129 
Three seven-channel ceramic UF membranes (INSIDE CéRAMTM, supplied by TAMI 130 
Industries, France) with a nominal pore size of 1, 5 and 8 kDa were used in order to 131 
represent a wide range of nominal MWCO within the fine UF range and to compare 132 
their effectiveness in PhACs removal. These membranes consisted of an active layer of 133 
TiO2 with an effective area of 132 cm2 and their dimensions were 25 cm long with an 134 
external diameter of 1 cm. 135 
 136 
2.3.Experimental procedure 137 
The filtration experiments were conducted in a standard cross-flow ultrafiltration set up 138 
that is schematically presented in Fig. 1. This cross-flow system was equipped with a 139 
temperature-controlled feed tank with a capacity of 20 L, a pH meter incorporated in 140 
the tank, a pre-filter to protect the pump of undesired pollution, a variable speed 141 
volumetric pump to adjust the feed flow (measured by a flow meter), and two 142 
manometers (P1 and P2, ranging from 0 to 6 bar) placed at the inlet and outlet streams 143 
of the membrane cell to adjust and control the transmembrane pressure. Finally, a scale 144 
with an accuracy of ± 0.001 g was used to gravimetrically measure the permeate flux. 145 
Before the filtration experiments began, water permeability (K) for each membrane 146 
using deionised water was calculated. These experiments were performed in the 147 
aforementioned standard cross-flow ultrafiltration set up at different transmembrane 148 
pressures (ΔP) ranging from 0.5 to 3 bar at a constant flow rate of 300 L·h-1. The water 149 
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permeability (K) was 38.2 ± 2.2, 40.4 ± 2.6, and 60.7 ± 3.6 L·m-2·h-1·bar-1 for the 150 
ceramic ultrafiltration membranes of 1, 5 and 8 kDa, respectively.  151 
 152 
The operating procedure was constituted by three different steps: firstly, the water flux 153 
of ceramic membranes was stabilised at a constant transmembrane pressure of 3 bar and 154 
300 L·h-1 of flow rate for at least 30 min until the difference between the measurements 155 
of consecutive permeate fluxes was lower than 2 % [25]. In the next stage, the filtration 156 
of different feed solutions containing the target PhACs was carried out at 300 ± 5 L·h-1, 157 
2 bar and 25 ± 1 ºC for 3 h. Two different feed solutions were separately used in this 158 
stage: the first one was prepared with an initial concentration of 1000 ng·L-1 of 159 
acetaminophen, ibuprofen, and sulfamethoxazole, and 300 ng·L-1 of caffeine, diazepam, 160 
diclofenac, erythromycin, naproxen, triclosan, and trimethoprim spiked in deionised 161 
water (Feed I), and the second one consisted of the same PhAC concentrations spiked in 162 
a WWTP secondary effluent (Feed II). Filtration experiments were performed in total 163 
recirculation mode (permeate samples were returned back to the feed tank to keep 164 
constant the feed concentration). In order to qualitatively and quantitatively assess the 165 
role of pH on the removal efficiencies, three pH levels (from pH 6 to 8) were tested on 166 
the basis of the literature about the removal of PhACs from WWTP secondary effluents 167 
and surface waters using membrane technologies [12,14,26,27].  168 
 169 
During filtration experiments, the permeate flux (Jp, L·m-2·h-1) was measured using the 170 




=           Eq. (1) 172 
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where m is the mass of permeate water (g), ρ is the density of water at the operating 173 
temperature (g·L-1), Am is the effective membrane area (m2), and t is the filtration time 174 
(h). 175 
 176 








=          Eq. (2) 178 
where Cp is the concentration of each PhAC in the permeate stream (ng·L-1), and Cf is 179 
the concentration of the same PhAC in the feed solution (ng·L-1).  180 
 181 
Once the filtration with the corresponding feed solution was finished, ceramic 182 
membranes were rinsed in cross-flow mode with deionised water to remove the 183 
reversible fouling from the membrane (Rrev, m-1). The duration of this step was 30 184 
minutes at 300 L·h-1, 1 bar and 25 ºC. In order to evaluate the influence of fouling 185 
phenomena on the flux decline and on the separation of PhACs during the filtration 186 
experiments, total hydraulic resistance (RT, m-1) can be determined from the Darcy’s 187 






=           Eq. (3) 190 
where μ is the viscosity of the feed solution (Pa·s). 191 
 192 
Therefore, this total hydraulic resistance comprises the different resistances that take 193 
place during the filtration process and can be defined as the sum of the membrane 194 
intrinsic resistance (obtained from the water permeability, K) and the hydraulic 195 




























        Eq. (6) 199 
irrrevmT RRRR ++=         Eq. (7) 200 
where Rm is the membrane intrinsic resistance (m-1), Jr is the permeate flux during the 201 
rinsing process (L·m-2·h-1), Rirr is the irreversible resistance due to fouling and can be 202 
defined as the permeate flux loss that can be recovered by chemical cleaning or even 203 
cannot be recovered (m-1), Jf is the permeate flux at the end of the filtration experiment 204 
with each feed solution (L·m-2·h-1), and Rrev is the reversible resistance caused by 205 
concentration-polarisation phenomenon and the filtration cake and can be defined as the 206 
permeate flux loss that can be recovered by physical cleaning (m-1) [28,29].  207 
 208 
In order to quantitatively assess the adsorption of PhACs during filtration of both feed 209 
solutions, mass balances based on the concentration of each PhAC in the feed, permeate 210 
and retentate streams were calculated using Eq. (8). Adsorbed mass (mads, ng·m-2) can 211 
be defined as the amount of PhAC adsorbed per unit area onto the membrane surface 212 







=        Eq. (8) 214 
where Cr is the concentration of each PhAC in the retentate stream (ng·L-1), and Vf, Vp, 215 
and Vr (L) are the volume of the same PhAC in the feed, permeate, and retentate stream, 216 











=        Eq. (9) 220 
 221 
2.4.Analytical methods 222 
Concentrations of PhACs in permeate, retentate and feed samples were determined by 223 
High-Performance Liquid Chromatography tandem-mass spectrometry (HPLC-MS/MS) 224 
method. An Agilent Technologies 1260 Infinity Ultra High-performance Liquid 225 
Chromatograph coupled to an Agilent Technologies 6410 Triple Quadrupole Mass 226 
Spectrometer with an electrospray Turbo V ionisation source and a C18 column 227 
(Kinetex, 1.7 μm, 100 Å, 50 x 2.10 mm) from Phenomenex (France) were used. The 228 
different PhACs concentrations were determined in both positive and negative 229 
ionisation modes, depending on the PhAC measured. Quantified and qualified 230 
transitions were optimised for each PhACs by selected reaction monitoring (SRM), 231 
which were previously described [13,23,30].  232 
 233 
The HPLC-MS/MS method was validated by determining seven-point calibration 234 
curves using standard solutions (which were injected in triplicate), where concentrations 235 
varied from the limit of quantification (LOQ) of each PhAC to 30 µg·L-1. The method’s 236 
integrity was evaluated by assessing the linearity, LOQ and limits of detection (LOD). 237 
The linearity of the method was evaluated by the linear correlation coefficient (R2), 238 
which was higher than 95 % for all the PhACs tested. The LOQ was calculated as the 239 
lowest amount of analyte added to the water sample that produced a peak signal of 10 240 
times the background noise in the chromatograph, while the LOD was expressed by the 241 
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equation LOD = LOQ/3. The values of LOD and LOQ for each PhAC are displayed in 242 
Table 3. 243 
 244 
3. RESULTS AND DISCUSSION 245 
3.1. Filtration of PhACs in deionised water (Feed I) 246 
The feed solution pH is an important parameter in the rejection of PhACs during the 247 
membrane separation process, regardless of whether model solutions with deionised 248 
water or real wastewater effluent were used. Like other emerging contaminants, the 249 
rejection indexes of PhACs vary with respect to their physicochemical properties, such 250 
as structure, molecular weight and dissociation constant (pKa). This latter property is 251 
linked to the strength of its inherent bonds and determines its ionic state. Due to the fact 252 
that MWCO of all the membranes tested is higher than the molecular weight of these 253 
PhACs, the electric charge property of each PhAC is an important factor that may affect 254 
the performance of the separation process. A change in feed solution pH can 255 
significantly vary the behaviour of a PhAC. One PhAC will be negatively charged at 256 
higher pH values than its pKa value; otherwise this PhAC will be neutral or positively 257 
charged or even a mixture of both. So, the rejection of PhACs is strongly dependent on 258 
the feed solution pH [12]. Fig. 2 shows the evolution of Jp(t)/J0 over filtration time for 259 
each ceramic membrane using Feed I. Despite the pore size of the membrane, the 260 
permeate flux slightly decreased with increasing pH, but this decline was lower than 10 261 
% of the initial permeate flux (J0). For this reason, the observed flux decline could be 262 
considered as insignificant; indicating that the effect of the adsorption and deposition of 263 
PhACs on the surface had no effect. This could be explained by the very low PhACs 264 
concentration used in this study (from 0.3 to 1 µg·L-1), which are too low to be 265 
influential. Comparing Fig. 2a, 2b, and 2c, permeate flux was higher for ceramic 266 
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membranes with larger MWCO at the same pH conditions. This is caused by the lower 267 
resistance offered by the membrane with larger pores for the solution to pass through it. 268 
 269 
The rejection index of each selected PhACs during the filtration experiments of Feed I 270 
with the three ceramic membranes at different pH conditions is depicted in Fig. 3. It can 271 
be seen that higher retention values were obtained using membranes with smaller 272 
nominal pore size, which indicates that membranes with low MWCO (close to NF 273 
range) are more selective in PhACs separation. In the same way, low retention values 274 
were achieved for almost all the PhACs tested, except for erythromycin, diclofenac, 275 
ibuprofen, naproxen, and sulfamethoxazole (with rejection indexes higher than 50 % 276 
using ceramic 1 kDa and 5 kDa membranes). The separation mechanism that prevails in 277 
UF process is generally based on the size exclusion or sieving effect, where solutes are 278 
solely separated according to their dimensions. This point of view is widely shared by 279 
several researchers but could be considered as insufficient, especially in this case, where 280 
the molecular weight of the PhACs is much smaller than the MWCO of an UF 281 
membrane. For this reason, the separation mechanism is not a simple sieve effect and 282 
cannot be considered as a simple filtration process, because the existing solute-solute 283 
and solute-membrane surface interactions (hydrophobic and electrostatic interactions) 284 
can play an important role in the retention of PhACs from different waters [12,31]. As 285 
was explained before, speciation of PhACs depends on their characteristic pKa value 286 
and the feed solution pH and then, it has a significant impact on their rejection. Several 287 
researchers demonstrated in their studies that the isoelectric point of the selected 288 
multichannel ceramic membranes was 6.2 ± 0.1, resulting in membranes with slightly 289 
positive charge at pH 6 and negative at pH 7 and 8 [32-34]. At pH 6, membranes 290 
showed higher rejections for erythromycin and trimethoprim compared to the other 291 
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PhACs for different reasons. Erythromycin existed as a neutral species at these 292 
conditions, while trimethoprim was positively charged. Despite being a non-ionic PhAC 293 
at the pH conditions tested (with a pKa value of 8.9), the high dipole moment of 294 
erythromycin (above 3 D) could be sufficient to induce an electrostatic attraction 295 
between the membrane surface and the polar centers of the molecule. These electrostatic 296 
interactions combined with the size exclusion due to the similarity of the molecular size 297 
of erythromycin with the nominal pore size of 1 kDa membrane could favour its 298 
retention [35,36]. In the case of 5 and 8 kDa membranes, the high rejection obtained for 299 
erythromycin could be explained taking into account that both membranes were 300 
hydrophilic in nature and changed their surface charge from positive to negative at pHs 301 
7 and 8, while erythromycin was hydrophobic (log KOW > 2) and remained neutral 302 
during all the experiments. The neutral charge of erythromycin could favour its 303 
adsorption on the negatively charged membrane surface because of electrostatic 304 
attraction, despite the different hydrophilicity between this compound and ceramic 5 305 
and 8 kDa membranes. Other authors have noted that the increasing rejection of 306 
erythromycin at basic pHs (< pKa) might be caused by the limited solubility of 307 
erythromycin in basic aqueous solutions, in which molecules may precipitate out of the 308 
aqueous feed solution and be adsorbed on the membrane surface [37]. For trimethoprim, 309 
its rejection value is higher than the other compounds at pH 6 mainly due to a weak but 310 
important electrostatic repulsion between the ceramic surface and trimethoprim, at 311 
which both the membrane and PhAC were positively charged. The charge of the 312 
ceramic membranes changed with increasing pH value from positive to negative, 313 
whereas trimethoprim was neutral at pH 7 and was negative at pH 8. At pH 7, such 314 
changes resulted in a significant decrease in its rejection index because both 315 
electrostatic and hydrophobic interactions (since trimethoprim was neutral and 316 
14 
 
hydrophilic at these conditions) were hindered. Due to the electrostatic repulsion 317 
between the molecules of trimethoprim and the ceramic surface, an increase in the 318 
rejection of trimethoprim was observed at pH 8, at which both had negative charge. 319 
Therefore, the rejection of trimethoprim had a similar behaviour at pH 6 and 8 when 320 
these multichannel ceramic membranes were used.  321 
 322 
The retention of PhACs is significantly greater at pH 8, especially for diclofenac, 323 
erythromycin, ibuprofen, naproxen, sulfamethoxazole, and trimethoprim. Despite their 324 
low molecular weight, rejection indexes of diclofenac, ibuprofen, naproxen, and 325 
sulfamethoxazole were higher with increasing pH values, due to the fact that these 326 
anionic compounds (pKa < 6) were electrostatically repulsed by the negatively charged 327 
surface. This increase in their rejection values indicated that the electrostatic repulsion 328 
between these anionic PhACs and the membrane surface was the predominant 329 
separation mechanism. These strong repulsive forces prevented their adsorption and/or 330 
diffusion through the membrane [38]. This statement was corroborated by other 331 
researchers, which demonstrated that the membrane adsorption of uncharged PhACs is 332 
higher than the same PhACs but with negative charge (such as ibuprofen) [39,40]. 333 
Moreover, this increasing trend was observed in the retention of diazepam, obtaining 334 
lower rejection values than the aforementioned organic compounds although diazepam 335 
had similar characteristics to them. Similar observation was also found in the retention 336 
of triclosan, where the rejection index was higher with increasing pH until a highest 337 
value obtained at pH 8, once the feed solution pH exceeded its characteristic pKa value 338 
[41]. Other PhACs such as acetaminophen and caffeine showed a pH-independent 339 
behaviour, presenting similar rejections at different pHs using the same ceramic 340 
membrane. Both compounds were neutral and hydrophilic during the filtration 341 
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experiments, indicating that the electrostatic interactions as well as the 342 
hydrophilic/hydrophobic affinity were not the predominant separation mechanisms. 343 
Other researchers observed similar pH-independent behaviour of carbamazepine and 344 
acetaminophen using different membrane technologies [39,42]. 345 
 346 
3.2. Filtration of PhACs in a WWTP secondary effluent (Feed II) 347 
In this section, the membrane performance during the filtration of Feed II (the selected 348 
PhACs added in a WTTP secondary effluent) is discussed in terms of flux decline, 349 
retention of PhACs, and effect of fouling phenomena. Fig. 4 shows the evolution of 350 
Jp(t)/J0 at different feed solution pHs as a function of time for each ceramic membrane. 351 
It can be observed that the flux decline was higher at pH 8 (where Jp(t)/J0 is 42.8, 34.2 352 
and 33.1 % for ceramic 8 kDa membrane at pH 6, 7 and 8, respectively), principally due 353 
to the adsorption and deposition of effluent organic matter (EfOM) onto the membrane 354 
surface. Jp rapidly decreased at low time scales in which the fast accumulation of 355 
retained solute particles from the WWTP secondary effluent occurred on the surface and 356 
within the membrane pores. After that period, a gradual but slow flux decline took 357 
place, reaching an almost constant value of Jp when the equilibrium between the 358 
attachment and detachment of foulants on the membrane was achieved [43]. Based on 359 
the effluent water quality and the results obtained in the previous section, the observed 360 
flux decline could be attributed to fouling phenomena by EfOM. The ceramic UF 361 
membranes used in this study are hydrophilic in nature, contrarily to the mostly 362 
hydrophobic EfOM presented in Feed II [44]. In addition, the inherent rougher surface 363 
of these membranes could favour the entrapment of solute molecules. Several 364 
researchers have demonstrated that ceramic membranes have rougher surfaces than 365 
polymeric membranes in the same MWCO range [28]. During the filtration 366 
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experiments, a foulant layer could be formed by adsorbed organic and inorganic 367 
compounds from Feed II onto the ceramic UF membrane and might act as a second 368 
barrier for separation. This fouling layer formed on the membrane surface is a 369 
hydrophobic and negatively charged layer, which reduces both the porosity and pore 370 
size of the ceramic membrane principally because both complete and intermediate pore 371 
blocking occurred during the first stages of the filtration [41,45]. As a result, the 372 
rejection values of some PhACs could be improved compared to those obtained for 373 
clean membranes [46]. Mousaab et al. confirmed the modification of the removal 374 
efficiencies of different PhACs (such as diclofenac, naproxen, ketoprofen and codeine) 375 
in the presence of biomass and organic solutes in an ultrafiltration membrane system 376 
coupled with biofilm biological reactor [47]. 377 
 378 
Due to the complexity of the different fouling mechanisms, the flux decline during 379 
filtration experiments using Feed II was investigated by calculating Rm, Rrev, Rirr, and 380 
RT. Their results are shown in Fig. 5, where the membrane with the highest water 381 
permeability showed the lowest Rm value (which was the ceramic 8 kDa membrane) and 382 
vice-versa. All the RT values are much higher for the membranes at pH 8 than at the 383 
other conditions tested, which indicates that ceramic membranes suffered more severe 384 
fouling at pH 8. The highest values of Rirr were also obtained for all the ceramic 385 
membranes at that pH, at which the strongest attachment of organic matter occurs. This 386 
fact is confirmed by the flux decline displayed in Fig. 4, where the highest irreversible 387 
fouling resistance and flux decline are remarkably for ceramic 8 kDa membrane (see 388 
Fig. 4c and 5c). Therefore, the effect of membrane fouling on PhAC rejection can be 389 
considered as relevant and thereby, the nominal pore size of membranes could affect the 390 
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extent of fouling, where more severe fouling (irreversible fouling) was observed in 391 
membranes with larger pore sizes [39,41]. 392 
 393 
The rejection indexes of selected PhACs for each pH tested during the filtration of Feed 394 
II are illustrated in Fig. 3. Higher PhACs rejections were obtained using real wastewater 395 
effluents (Feed II) than those obtained when PhACs were spiked in deionised water 396 
(Feed I). This fact may be mainly because of the presence of EfOM (mostly 397 
hydrophobic) in the membrane structure, especially adsorbed on the surface due to 398 
fouling phenomena (as was explained before). The hydrophobic/adsorptive separation 399 
mechanism became more important in the rejection of PhACs due to the presence of 400 
organic matter in the feed solution and the hydrophobic nature of the fouling layer 401 
formed on the membrane surface. As a result, the degree of PhACs rejection depended 402 
on both the pH and ionic strength of the aqueous feed solution, and also on the presence 403 
of organic matter. Some PhACs became charged at different pH conditions (as was 404 
indicated in the previous section) and could be adsorbed onto colloids, trapped by 405 
organic matter or associated with cations in the feed solution [12]. Such rejections could 406 
be explained by two mechanisms: EfOM fouling and solute-solute interactions. The 407 
accumulation of organic matter on the membrane surface during filtration (caused by 408 
EfOM fouling) might act as an additional secondary barrier that could modify the 409 
separation mechanism of PhACs. This supplementary filtration layer (or foulant layer) 410 
was generally hydrophobic and negatively charged, which contrasted with the 411 
hydrophilic ceramic membrane. In such conditions, the rejection of some PhACs could 412 
increase by the repulsion between the negative charge of the additional foulant layer and 413 
the negatively charged PhACs and also by the hydrophobic interactions between the 414 
foulant layer and PhACs. In the same way, solute-solute interactions in effluent matrix 415 
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had a relevant role on PhACs rejections. The association of PhACs with organic 416 
macromolecules in the effluent led to form EfOM-compounds complexes that could be 417 
the result of hydrogen bonding and electrostatic attraction between the polar moieties of 418 
PhAC molecules and the phenolic or carboxylic groups of the humic-like substances. 419 
These complexes could be rejected by sieving effect or charge repulsion between them 420 
and the membrane surface [48-50]. This new scenario can be seen in Fig. 3. When the 421 
rejection values in Feed I are compared with those obtained during filtration of Feed II, 422 
the presence of organic matter and the EfOM-compound complexation improve the 423 
rejection indexes of most of the PhACs, especially in the rejection of neutral and 424 
negative compounds. Nevertheless, sulfamethoxazole showed the opposite behaviour, 425 
presenting lower rejection values in the presence of Feed II. This interesting fact was 426 
observed by other researchers using nanofiltration membranes, who demonstrated that 427 
the reduction in the rejection value could be provoked by the inherent high dipole 428 
moment of sulfamethoxazole (7.366 D), which electrostatically attracted the molecule to 429 
the membrane pores to facilitate its diffusion and permeate in an oriented way [36,41]. 430 
This proves that polarity of PhACs could have a more important influence on rejection 431 
in real wastewaters or effluents than in model solutions with pure water [50].  432 
 433 
With respect to PhACs separation during filtration of Feed II, PhACs rejections are 434 
higher for membranes with smaller nominal pore size (retention values were higher for 435 
ceramic 1 kDa membrane than for both membranes with MWCO of 5 kDa and 8 kDa). 436 
The influence of feed solution pH on PhACs rejection is clearly visible, obtaining 437 
higher rejection values with increasing pH conditions, except for trimethoprim, 438 
acetaminophen and caffeine. This could be related to the hydrophilic character of these 439 
compounds at the studied pH range. The hydrophobicity of PhACs is typically 440 
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evaluated using the octanol-water partition coefficient of a compound (KOW) or its 441 
logarithm (log KOW) that can be used as a descriptor of the sorption potential and 442 
bioaccumulation of a compound in the aquatic environment. Log KOW is generally used 443 
for uncharged (neutral) compounds [51]. In this study, acetaminophen, caffeine and 444 
erythromycin existed as neutral species during all the experiments. By contrast, 445 
hydrophobicity and solubility of a compound changes as a function of pH, especially in 446 
a pH range around the pKa value. In these cases, solute hydrophobicity is predicted 447 
using log DOW (a pH-corrected value of log KOW) that considers the ratio between the 448 
ionised and unionised form of the compound at a specific pH value. Log KOW and log 449 
DOW are the same for non-ionisable compounds. A compound can be considered as 450 
hydrophobic when its characteristic log DOW (or log KOW) is higher than 2, whereas the 451 
same compound is hydrophilic when it has a log DOW (or log KOW) value below 2 [26]. 452 
In order to properly analyse the rejection of PhACs that were in ionic state within the 453 
studied pH range, Table 4 represents the log DOW values of the PhACs that are not 454 
neutral (pKa < feed solution pH) at the tested pH conditions. At pH 6, trimethoprim was 455 
positively charged and highly hydrophilic (log DOW: 0.27). At these conditions, the 456 
effect of fouling on the ceramic membranes was less relevant compared to the fouling 457 
resistances obtained at higher pH conditions and two opposite effects affected the 458 
rejection efficiencies of this compound: the electrostatic attraction between the formed 459 
foulant layer on the membrane surface (which is negatively charged in general) and the 460 
cationic compound, and the difference between the hydrophilic compound (with low 461 
sorption potential, log DOW < 2, see Table 4) and the hydrophobic foulant layer. In this 462 
case, the electrostatic attraction became the main separation mechanism and could lead 463 
to an accumulation of molecules of trimethoprim at the vicinities of the formed foulant 464 
layer, being adsorbed and increasing its rejection. At pH 7, such electrostatic attraction 465 
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forces did not exist because trimethoprim was a neutral species and hence, hydrophilic 466 
non-ionic trimethoprim was not adsorbed on the foulant layer. Also, uncharged 467 
trimethoprim had a smaller molecular weight than the nominal pore size of the ceramic 468 
membranes (size exclusion was not the major rejection mechanism), passing through 469 
the membrane matrix [52]. Although trimethoprim was less hydrophilic at pH 8 (its log 470 
DOW are higher with increasing pH), charge repulsion was the dominant mechanism to 471 
reject this compound because both trimethoprim and foulant layer are negatively 472 
charged. For acetaminophen and caffeine, their rejection values slightly increased in 473 
Feed II compared to Feed I. However, the stable rejection profile of both compounds 474 
was relatively pH-independent due to their neutral form and high hydrophilicity. Both 475 
acetaminophen and caffeine had a log KOW value lower than 0.5, indicating their high 476 
hydrophilic character. Therefore, the formation of a foulant layer on the membrane 477 
surface barely altered the rejection values of such compounds regardless of the 478 
membrane used. Sheng et al. confirmed that acetaminophen and caffeine showed the 479 
same behaviour in ultrafiltration experiments with real wastewater effluent [53]; 480 
whereas Mahlangu and colleagues demonstrated that the presence of a foulant layer 481 
(colloidal and inorganic molecules as foulants) on the membrane surface did not alter 482 
the rejection of caffeine using a polyamide NF-270 membrane [54].  483 
 484 
High rejection results (> 70 %) were observed for diclofenac (75.9%), diazepam (72.6 485 
%), erythromycin (85.4 %), and triclosan (72.9 %) during filtration experiments using 486 
ceramic 1 kDa membrane at pH 8. As explained in the previous section, the high 487 
rejection of erythromycin could be inferred as a combination of adsorption and 488 
electrostatic attraction between the foulant layer and this compound. This was probably 489 
due to its higher molecular weight (733.94 g·mol-1), hydrophobicity (log KOW: 3.06), 490 
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neutral charge, and high dipole moment (3.99 D). In spite of not being the main 491 
separation mechanism for erythromycin, size exclusion became more important under 492 
these conditions due to the formation of EfOM-erythromycin complexes, which led to 493 
an increase in the size of such complexes and thus, the highest rejection of all the 494 
PhACs was achieved. In the case of the rejection of triclosan, its pKa value was 495 
reported to be 7.8, indicating that this compound would exist in both neutral and ionised 496 
forms on the operating pH conditions of the most WWTPs, which are within the range 497 
of pH 8 approximately. The formation of the negative species of the triclosan at pH 8 498 
could result in an increase in the rejection values of this compound due to the 499 
electrostatic repulsion between this ionic triclosan and the negatively charged 500 
membrane surface (as explained in the previous section). However, the intrinsic 501 
hydrophobic nature of triclosan (with log DOW > 2, see Table 4) could significantly 502 
increase its rejection values during the filtration experiments with real wastewater 503 
effluents, regardless of its neutral or ionic state. According to several authors, PhACs 504 
with high log DOW (> 4.5) have a high sorption potential and could be easily adsorbed 505 
on hydrophobic surfaces, such as hydrophobic polymeric membranes or even the 506 
biofilm and foulant layer formed onto the membrane surface caused by fouling 507 
phenomena [55]. This could explain the high retention of triclosan at all the tested pH 508 
conditions, especially at pH 8, once its characteristic pKa value (7.8) was exceeded 509 
[41,56]. Similar observation was also found for diclofenac, where its high rejection 510 
values may be related to its high characteristic log KOW and log DOW values (4.64 and 511 
4.28, respectively), which this organic compound could be adsorbed on the hydrophobic 512 
foulant layer formed onto the ceramic surface. Diazepam showed quite hydrophobicity 513 
and negative charge (pKa < feed solution pH) at these pH conditions, where the 514 
electrostatic repulsion between the foulant layer and this anionic compound could 515 
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favour its rejection. In the same way, Lopez-Fernandez and her colleagues demonstrated 516 
that diazepam was partially adsorbed by the submerged hydrophobic UF membrane due 517 
to the hydrophobic solute-membrane interactions [57].  518 
 519 
Moreover, rejection values higher than 50 % were obtained at pH 8 for ibuprofen, 520 
naproxen, and sulfamethoxazole, increasing from 44.3, 44.7, and 26.4 % at pH 6 to 521 
62.4, 61.3, and 57.5 % at pH 8, respectively. The main separation mechanism for such 522 
PhACs was electrostatic repulsion with the negatively charged surface of both foulant 523 
layer and ceramic membrane (as was observed in the previous section). However, the 524 
feed solution pH had a considerable effect on the hydrophobicity and solubility of such 525 
compounds, which caused an improvement in their rejection. These PhACs were 526 
negatively charged at the entire pH range tested, but they presented different 527 
hydrophilicity: ibuprofen and naproxen were hydrophobic while sulfamethoxazole was 528 
hydrophilic. The pH-dependence of their hydrophobicity can be observed in Table 4 and 529 
Fig. 6, where the values of log DOW of ibuprofen, naproxen, and sulfamethoxazole 530 
decreased when pH increased. This indicates that such compounds became more 531 
hydrophilic at higher pH values, especially for naproxen and sulfamethoxazole with log 532 
DOW < 0 (no sorption potential). Nghiem and Hawkes demonstrated that the solubility of 533 
ibuprofen and sulfamethoxazole significantly increased at neutral and basic conditions, 534 
resulting in a decrease in the hydrophobicity of the anionic ibuprofen [39]. This change 535 
in hydrophobicity for ibuprofen and naproxen at pH 8 was also observed by Jin et al. 536 
[58]. Therefore, the decrease in hydrophobicity at higher pHs together with the 537 
electrostatic repulsion between the negative foulant layer (which acts as a 538 
supplementary hydrophobic membrane onto the ceramic hydrophilic membrane) and 539 
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such negative molecules result in a remarkable improvement of their removal (see Fig. 540 
3).  541 
 542 
3.3. PhAC adsorption 543 
In order to understand the retention mechanisms for the selected PhACs during filtration 544 
experiments, PhACs adsorption was quantitatively assessed by applying mass balances 545 
based on the concentration of each PhAC in the feed, permeate and retentate. The 546 
percentages of the adsorbed mass or adsorption percentage (Mads) of each PhAC and 547 
membrane for Feed I and Feed 2 are listed in Table 5 and 6, respectively. It must be 548 
remarked that the results of Mads reflect not only the adsorption onto the membrane 549 
surface and pore walls but also the amount adsorbed on the foulant layer (during 550 
filtration of Feed II). Very low adsorption percentages (< 0.1 %) of PhACs were 551 
obtained during filtration of Feed I (see Table 5). As expected, the adsorption of PhACs 552 
on ceramic ultrafiltration membranes was very limited. Hydrophobic PhAC molecules 553 
could not be adsorbed onto the hydrophilic ceramic surface, but can be entrapped due to 554 
its roughness, as was explained before in fouling analysis. Similar percentages can be 555 
observed for each PhAC and membrane with very small differences (which cannot be 556 
considered as significant) associated with the PhACs properties (such as charge and 557 
hydrophilicity). However, higher adsorption percentages were found for Feed II (see 558 
Table 6), especially for hydrophobic compounds (diazepam, diclofenac, erythromycin, 559 
ibuprofen, naproxen, and triclosan). This fact may be because the higher hydrophobic 560 
character (high sorption potential) of a compound results in a higher adsorption on the 561 
hydrophobic separation layer, and it can be even increased when this compound is 562 
neutral (such as erythromycin within the studied pH range and triclosan at pH 6 and 7). 563 
The adsorbed mass of both acetaminophen and caffeine (hydrophilic and neutral 564 
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PhACs) is almost constant at each pH, which confirms their pH-independent behaviour. 565 
In the same way, a decline in the adsorbed mass of ibuprofen, naproxen and 566 
sulfamethoxazole on the hydrophobic foulant layer formed onto the membranes can be 567 
seen in Table 6. As discussed previously, an increasing pH enhances the solubility of 568 
ibuprofen, naproxen and sulfamethoxazole in an aqueous solution and hence, may 569 
reduce the hydrophobic character of these PhACs. This improvement in their apparent 570 
hydrophilic character leads to lower adsorptions during filtration. The highest 571 
adsorptions observed were for diclofenac and triclosan (Mads between 8 and 12 % at pH 572 
8). Due to their high hydrophobic character (log KOW > 4.5 and log DOW > 4.2), 573 
diclofenac and triclosan were strongly adsorbed by hydrophobic interactions with the 574 
foulant layer [57], as was explained before. Finally, the behaviour of trimethoprim is 575 
also corroborated with the results shown in Table 6, where the highest adsorbed mass of 576 
this compound was found at pH 6 due to the charge attraction between its positive 577 
molecules and the negatively charged foulant layer.  578 
 579 
4. CONCLUSIONS 580 
In order to elucidate the influence of feed solution pH and fouling phenomena on the 581 
removal of emerging contaminants, the rejection of ten selected PhACs with different 582 
physicochemical characteristics (such as molecular weight, water solubility, log KOW, 583 
pKa, dipole moment, and charge) using ceramic ultrafiltration membranes was 584 
investigated. As expected, ceramic membranes with smaller nominal pore size showed 585 
higher rejection values than the larger ceramic membranes. Variations in the pH 586 
conditions demonstrated the key role of pKa and log KOW on the rejection of 587 
pharmaceutically active compounds, obtaining higher removal efficiencies at basic pHs, 588 
especially for anionic compounds. The study of the rejection of anionic compounds 589 
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demonstrated that electrostatic repulsion was the predominant mechanism in the 590 
rejection of ionic compounds, especially when feed solutions formed by PhACs spiked 591 
in deionised water were used. However, hydrophobic/hydrophilic interactions and the 592 
adsorptive mechanism gained importance when real wastewater effluent was used. The 593 
hydrophilic character and solubility of the anionic compounds improved with increasing 594 
pH up to 8 (slightly alkaline), at which anionic compounds were effectively rejected at 595 
basic pHs. Non-ionic erythromycin was the only compound that was significantly 596 
affected by the sieving effect due to its similarities between the molecular weight of this 597 
compound and the nominal pore size of the smallest ceramic membrane tested (ceramic 598 
1 kDa membrane). Therefore, the experimental results highlighted that the geometry, 599 
dipole moment, charge and hydrophobicity of the compound plays an active role in the 600 
membrane rejection, even more than its molecular weight. Membrane fouling was also 601 
influenced by the pH variations of the feed solution, observing higher irreversible 602 
fouling at slightly alkaline pHs. At these conditions, PhACs rejection was higher. Thus, 603 
the resulting foulant layer formed onto the membrane surface improved the adsorption 604 
of some compounds and the charge repulsions between anionic compounds and the 605 
negatively charged membrane surface. In the same way, the formation of EfOM-PhACs 606 
complexes as a result of the association of PhACs with organic macromolecules 607 
significantly improved the rejection of neutral compounds such as erythromycin. The 608 
reported results indicated that the rejection of PhACs was strongly pH-dependent, 609 
except for hydrophilic neutral compounds (acetaminophen and caffeine), which showed 610 
a pH-independent behaviour with low rejection values.  611 
 612 
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7. LIST OF SYMBOLS 797 
Variables 798 
Am  Effective area of the membrane (m2) 799 
Cf  Concentration of each pharmaceutically active compound in the feed  800 
  stream (ng·L-1) 801 
Cp  Concentration of each pharmaceutically active compound in the permeate 802 
  stream (ng·L-1) 803 
Cr  Concentration of each pharmaceutically active compound in the retentate 804 
  stream (ng·L-1) 805 
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J0  Initial permeate flux (L·m-2·h-1) 806 
Jf  Permeate flux at the end of filtration experiments (L·m-2·h-1) 807 
Jp  Permeate flux (L·m-2·h-1) 808 
Jr  Permeate flux during the rinsing process (L·m-2·h-1) 809 
K  Water permeability (L·m-2·h-1·bar-1) 810 
LOD  Limit of detection of a compound (ng·L-1) 811 
log DOW pH-corrected value of the logarithm of the octanol-water partition  812 
  coefficient (dimensionless) 813 
log KOW Logarithm of the octanol-water partition coefficient (dimensionless) 814 
LOQ  Limit of quantification of a compound (ng·L-1) 815 
m  Mass of permeate water (g) 816 
mads  Adsorbed mass of a compound (ng·m-2) 817 
Mads  Adsorption percentage (%) 818 
MWCO Molecular weight cut-off (Da) 819 
pKa  Dissociation constant (dimensionless) 820 
R  Solute rejection index (%) 821 
Rirr  Membrane irreversible resistance (m-1) 822 
Rm  Membrane intrinsic resistance (m-1) 823 
Rrev  Membrane reversible resistance (m-1) 824 
RT  Membrane total resistance (m-1) 825 
t  Filtration time (h) 826 
T  Temperature (°C) 827 
V  Total volume permeated during an experimental time interval (L) 828 
Vf   Volume of each PhAC in the feed stream (L) 829 
Vp  Volume of each PhAC in the permeate stream (L) 830 
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Vr  Volume of each PhAC in the retentate stream (L) 831 
ΔP  Transmembrane pressure (bar) 832 
ρ   Density of water at the operating temperature (g·L-1) 833 
 834 
Abbreviations 835 
APIs  Active pharmaceutical ingredients 836 
DBPs  Disinfection by-products 837 
EDCs  Endocrine disrupting compounds 838 
EfOM  Effluent organic matter 839 
HPLC  High-Performance liquid chromatography 840 
LC-MS/MS Liquid chromatography tandem-mass spectrometry 841 
MF  Microfiltration 842 
NF  Nanofiltration 843 
NOM  Natural organic matter 844 
PCPs  Personal care products 845 
PhACs  Pharmaceutically active compounds 846 
RO  Reverse osmosis 847 
SRM  Selected reaction monitoring 848 
UF  Ultrafiltration 849 
WWTPs Wastewater treatment plants 850 
 851 
Table 1. Characteristics of the secondary effluents from a local wastewater treatment plant at 25 ºC. 
Parameter Feed solutiona 
pH 7.98 ± 0.13 
m-Alkalinity (mg CaCO3·L-1) 340.12 ± 13.55 
Electrical conductivity (µS·cm-1) 1574.50 ± 36.81 
TSS (ppm) 157.00 ± 53.92 
Turbidity (NTU) 19.43 ± 1.96 
COD (mg O2·L-1) 86.02 ± 12.59 
UV254 0.504 ± 0.002 
Total Nitrogen (mg N·L-1) 73.30 ± 16.10 
Proteins (mg·L-1) 65.25 ± 10.03 






Table 2. Physicochemical properties of the selected PhACs studied. 
Pharmaceutical 














Acetaminophen 103-90-2 C8H9NO2 151.166 0.494 9.86 0 Hydrophilic 3.850 121.0 
Caffeine 58-08-2 C8H10N4O2 194.194 -0.040 10.4 0 Hydrophilic 3.401 133.9 
Diazepam 439-14-5 C16H13ClN2O 284.746 2.820 3.4 -1 Hydrophobic 2.173 226.0 
Diclofenac 15307-79-6 C14H10Cl2NNaO2 318.136 4.640 4.08 -1 Hydrophobic 2.508 207.0 
Erythromycin 114-07-8 C37H67NO13 733.942 3.060 8.9 0 Hydrophobic 3.988 611.6 
Ibuprofen 15687-27-1 C13H18O2 206.286 3.679 4.40 -1 Hydrophobic 1.223 200.5 
Naproxen 22204-53-1 C14H14O3 230.265 2.816 4.15 -1 Hydrophobic 2.838 192.4 
Sulfamethoxazole 723-46-6 C10H11N3O3S 253.283 0.564 5.7 -1 Hydrophilic 7.366 173.2 
Triclosan 3380-34-5 C12H7Cl3O2 289.546 5.529 7.8 0 Hydrophobic 2.450 194.3 
Trimethoprim 738-70-5 C14H18N4O3 290.32 0.981 6.6-7.1 +1 Hydrophilic 2.535 231.9 
aSciFinder Scholar, data calculated at 20ºC and 760 torr using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-
2016 ACD/Labs). 
bHydrophobic when log KOW > 2. 









Table 3. Selecting validation parameters for the HPLC-MS/MS method, where LOD is the limit of 
detection and LOQ is the limit of quantification (LOQ) for each compound tested. 
Compound LOD (ng·L-1) LOQ (ng·L-1) 
Acetaminophen 0.9 2.7 
Caffeine 0.6 1.8 
Diazepam 1.0 3.0 
Diclofenac 0.3 1.0 
Erythromycin 6.0 18.0 
Ibuprofen 5.0 15.0 
Naproxen 0.5 1.5 
Sulfamethoxazole 0.9 2.7 
Triclosan 0.3 1.0 










Table 4. Log DOW values calculated for PhACs that are not neutral (pKa < feed solution pH) at the tested 
pH conditions. 
Pharmaceutical 
active compound Calculated Log DOW
a 
 pH 6 pH 7 pH 8 
Diazepam 3.08 3.08 3.08 
Diclofenac 4.28 4.28 4.28 
Ibuprofen 2.67 1.71 0.85 
Naproxen 1.18 0.25 -0.36 
Sulfamethoxazole 0.60 0.14 -0.11 
Triclosan 4.97 4.90 4.50 
Trimethoprim 0.27 0.92 1.23 










Table 5. Adsorption percentage of each PhAC for different ceramic membranes using Feed I within the 
studied pH range calculated by mass balances. 
Compound Mads (%) for Feed I 
 pH 6 pH 7 pH 8 
 1 kDa 5 kDa 8 kDa 1 kDa 5 kDa 8 kDa 1 kDa 5 kDa 8 kDa 
Acetaminophen 0.066 0.041 0.026 0.069 0.042 0.032 0.069 0.044 0.034 
Caffeine 0.044 0.030 0.018 0.043 0.031 0.021 0.046 0.031 0.024 
Diazepam 0.046 0.044 0.038 0.049 0.048 0.042 0.056 0.053 0.049 
Diclofenac 0.071 0.049 0.029 0.076 0.057 0.049 0.076 0.068 0.056 
Erythromycin 0.076 0.073 0.063 0.074 0.076 0.070 0.064 0.076 0.074 
Ibuprofen 0.072 0.043 0.036 0.076 0.057 0.048 0.076 0.070 0.053 
Naproxen 0.057 0.043 0.021 0.072 0.064 0.036 0.077 0.070 0.044 
Sulfamethoxazole 0.073 0.071 0.036 0.076 0.074 0.050 0.067 0.077 0.055 
Triclosan 0.058 0.041 0.030 0.074 0.054 0.049 0.074 0.063 0.045 




Table 6. Adsorption percentage of each PhAC for different ceramic membranes using Feed II within the 
studied pH range calculated by mass balances. 
Compound Mads (%) for Feed II 
 pH 6 pH 7 pH 8 
 1 kDa 5 kDa 8 kDa 1 kDa 5 kDa 8 kDa 1 kDa 5 kDa 8 kDa 
Acetaminophen 6.142 6.096 5.324 6.044 6.191 5.716 6.149 6.116 5.757 
Caffeine 5.290 4.459 2.094 5.084 4.746 2.019 4.660 4.730 2.257 
Diazepam 7.324 6.734 5.369 8.428 7.002 5.582 8.488 8.097 6.559 
Diclofenac 7.392 6.267 7.093 8.985 7.711 8.488 10.121 8.317 9.636 
Erythromycin 6.214 6.977 6.908 7.791 8.369 7.469 8.981 9.549 7.941 
Ibuprofen 8.452 7.799 7.393 7.583 7.545 5.853 7.025 6.342 5.640 
Naproxen 8.274 8.131 6.368 7.975 7.016 5.811 7.599 5.854 5.611 
Sulfamethoxazole 7.608 7.121 5.773 6.975 5.982 5.101 5.946 5.302 4.165 
Triclosan 7.308 4.934 4.913 8.110 8.101 8.159 9.963 11.168 11.464 
Trimethoprim 7.190 6.909 5.026 5.791 4.746 3.619 6.200 5.132 3.993 
 
 

























































Fig. 2. Evolution of Jp(t)/J0 over time (3 h) during filtration experiments of Feed I at different pHs for: a) 
ceramic 1 kDa membrane, b) ceramic 5 kDa membrane, and c) ceramic 8kDa membrane. Experimental 
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Fig. 3. Rejection values of PhACs during filtration experiments of Feed I and Feed II at different pHs for: 
a) ceramic 1 kDa membrane, b) ceramic 5 kDa membrane, and c) ceramic 8kDa membrane. Experimental 






































































Fig. 4. Evolution of Jp(t)/J0 over time (3 h) during filtration experiments of Feed II at different pHs for: a) 
ceramic 1 kDa membrane, b) ceramic 5 kDa membrane, and c) ceramic 8kDa membrane. Experimental 




Fig. 5. Intrinsic membrane resistance (Rm), reversible fouling resistance (Rrev), irreversible fouling 
resistance (Rirr), and total fouling resistance (RT) of each ceramic ultrafiltration membrane determined 
from filtration of PhACs in Feed II: a) ceramic 1 kDa membrane, b) ceramic 5 kDa membrane, and c) 




































Fig. 6. Rejection values of ibuprofen (●), naproxen (■), and sulfamethoxazole (∆) during filtration 
experiments of Feed II as a function of the pH-corrected octanol-water partition coefficient (Log DOW). 
Coloured arrows indicate the evolution of feed solution pH from 6 to 8. Experimental conditions: 2 bar, 
300 L h-1, and 25 ± 2 ºC. 
